( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.

AI Optics, a biotech startup backed by NYU Langone and raising in stealth, announced clearance this week from the Food and ...

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

The U.S. Food and Drug Administration (FDA) has taken a crucial step to protect public health: it has banned the use of Red Dye No. 3 in all food products. This synthetic dye, known for giving a ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The growing impacts of avian flu around the globe struck close to home this month with the outbreak at the Crescent Duck Farm in Aquebogue.

In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...

It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids and over-the-counter medications.

A December recall on Lay’s Potato Chips sold in two states has been escalated to the FDA’s highest risk level, but no ...

Any NYT reader looking at the buzzy front page headline below would immediately think that Robert F. Kennedy Jr. is a madman. Can he really be an advocate for repealing the polio vaccine, a disease ...

Thus, the First Department found that the defendants, who “purposefully availed themselves of the privilege of conducting activities in New York,” failed to present a compelling case that the presence ...

The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with ...